▾

External sources (not reviewed)

improving access to more efficacious combination regimens.

determining when outreach activities should be conducted to address gaps in the roster, especially in gender and geographic representation, and determining the mobility opportunities for staff members currently serving in the field so as to rotate staff among relevant duty stations.

MDIs through third parties; and to support the MDI transition strategy.

and international objectives, a view that his country was not alone in holding or putting into practice.

products, but not with the intention to replace CFC-MDIs as therapeutic treatment for asthma and COPD for all patients.

use is the amount of active ingredient used 1.5 times.

through the process recommended by the General Assembly.

law, the Charter of the United Nations and the norms and principles governing relations among States and constituted gross violations of human rights, particularly economic, social and cultural rights, the right to a decent life and the right to development.

awareness-raising measures for chemical industry representatives and manufacturers; voluntary codes of conduct for the reporting of suspicious transactions; participation in international special measures for the surveillance of precursors as part of Project PRISM and Project Cohesion; and expert group conferences such as the Synthetic Drug Enforcement Conference held in Nunspeet, the Netherlands, in November 2007, which highlighted trends, new chemicals and legislative weaknesses.

opportunity to purchase a small number of doses at an affordable cost.

methyl bromide as a soil fumigant in Morocco, and the terminal CTC phase-out project in Serbia; and for Spain, the phase-out of methyl bromide in horticulture in Libyan Arab Jamahiriya.

of US $401,500 plus agency support costs of US $30,113 for UNDP, noting that the project was consistent with decision 55/43(e) and that it had been designed to disseminate the results from the validation of methyl formate technology in rigid and integral skin polyurethane foam applications globally, and on the understanding that the project would be the final validation project for methyl formate in the manufacture of rigid and integral skin polyurethane foams, and that approval of the project was without prejudice to consideration of the future funding request for phase II of the project by the Executive Committee.

presenting a risk of asphyxiation when used for cooling or conditioning purposes; the use of salvage pressure receptacles and the use, design, construction, inspection, testing and handling of flexible bulk containers; and the use of electronic data interchange for documentation purposes.